← LIFECORE BIOMEDICAL, INC. \DE\
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $541.1m |
$532.3m
-1.63%
|
$524.2m
-1.51%
|
$557.6m
+6.36%
|
$590.4m
+5.88%
|
$544.2m
-7.83%
|
$185.8m
-65.86%
|
$103.3m
-44.42%
|
$128.3m
+24.20%
|
$128.9m
+0.47%
|
$128.9m
0.00%
|
|
| Cost of Revenue | $470.1m |
$449.1m
-4.48%
|
$445.9m
-0.71%
|
$476.6m
+6.88%
|
$515.4m
+8.15%
|
$462.7m
-10.22%
|
$135.4m
-70.73%
|
$75.3m
-44.41%
|
$86.4m
+14.78%
|
$88.6m
+2.50%
|
$88.6m
0.00%
|
|
| Gross Profit | $71.0m |
$83.2m
+17.23%
|
$78.3m
-5.83%
|
$81.0m
+3.40%
|
$75.0m
-7.43%
|
$81.5m
+8.65%
|
$50.4m
-38.18%
|
$28.0m
-44.44%
|
$41.9m
+49.54%
|
$40.3m
-3.71%
|
$40.3m
0.00%
|
|
| Research and Development Expense | $7.2m | $9.5m | $12.8m | $11.5m | $11.1m | $10.2m | $7.8m | $8.7m | $8.6m | $8.3m | $8.3m | |
| Selling, General and Administrative Expense | $49.5m | $55.6m | $52.0m | $64.1m | $72.2m | $65.4m | $46.1m | $39.0m | $40.5m | $44.0m | $44.0m | |
| Amortization of Intangible Assets | ($867k) | $885k | $969k | $1.5m | $2.0m | $2.0m | $1.4m | $0 | $0 | — | — | |
| Restructuring Costs | — | — | — | — | $17.3m | $17.6m | $9.0m | $4.2m | — | — | — | |
| Operating Expenses | $90.7m | $67.7m | $64.8m | $75.5m | $113.5m | $95.0m | $109.0m | $49.8m | $50.7m | — | $140.9m | |
| Operating Income (Loss) | ($19.8m) |
$15.5m
+178.36%
|
$13.6m
-12.37%
|
$5.5m
-59.70%
|
($38.5m)
-803.87%
|
($13.5m)
+64.98%
|
($58.6m)
-334.56%
|
($21.8m)
+62.84%
|
($8.8m)
+59.42%
|
($17.2m)
-94.99%
|
($12.0m)
+30.38%
|
|
| Interest Expense | $2.0m | — | — | — | — | — | $17.4m | $17.6m | — | — | $21.8m | |
| Interest Expense, Debt | — | — | — | — | — | — | — | — | — | $22.2m | $21.8m | |
| Gain (Loss) Related to Litigation Settlement | — | ($2.6m) | — | $0 | — | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | $1.2m | $900k | $2.9m | $1.6m | ($4.4m) | ($11.7m) | $641k | ($1.2m) | ($3.1m) | ($3k) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $18.9m | $15.0m | $16.4m | $3.6m | ($51.3m) | ($40.5m) | ($69.5m) | ($63.9m) | $9.5m | ($38.7m) | ($38.7m) | |
| Current Income Tax Expense (Benefit) | $2.4m | $1.8m | ($2.7m) | $79k | ($7.7m) | $92k | $379k | $54k | $27k | $162k | $43k | |
| Income Tax Expense (Benefit) | ($7.4m) | $4.3m | ($9.4m) | $1.5m | ($13.1m) | ($7.8m) | ($5.9m) | $308k | $183k | $43k | $43k | |
| Net Income (Loss) Attributable to Parent | ($11.6m) |
$10.6m
+190.97%
|
$24.8m
+134.46%
|
$411k
-98.34%
|
($38.2m)
-9392.21%
|
($32.7m)
+14.47%
|
($114.7m)
-251.08%
|
($99.6m)
+13.18%
|
$12.0m
+112.07%
|
($38.7m)
-422.29%
|
($44.4m)
-14.57%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | — | — | — | — | — | — | $12.0m |
($44.4m)
-469.26%
|
($44.4m)
0.00%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $193k | $87k | $94k | $0 | $0 | — | — | — | — | — | ($44.4m) | |
| Preferred Stock Dividends, Income Statement Impact | — | — | — | — | — | — | — | — | $0 | $3.3m | $3.3m | |
| Earnings Per Share, Basic | ($0.43) | $0.39 | $0.90 | $0.01 | ($1.31) | ($1.12) | ($3.90) | ($3.32) | $0.40 | ($1.27) | ($1.27) | |
| Earnings Per Share, Diluted | ($0.43) | $0.38 | $0.89 | $0.01 | ($1.31) | ($1.12) | ($3.90) | ($3.32) | $0.32 | ($1.27) | ($1.27) | |
| Income (Loss) from Continuing Operations, Per Basic Share | ($0) | $0 | $1 | $0 | ($1) | ($1) | ($2) | ($2) | $0 | ($1) | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | ($0) | $0 | $1 | $0 | ($1) | ($1) | ($2) | ($2) | $0 | ($1) | — | |
| Weighted Average Number of Shares Outstanding, Basic | 27.0m | 27.3m | 27.5m | 28.4m | 29.2m | 29.3m | 29.5m | 30.0m | 30.5m | 34.8m | 34.8m | |
| Weighted Average Number of Shares Outstanding, Diluted | 27.0m | 27.7m | 27.9m | 28.6m | 29.2m | 29.3m | 29.5m | 30.0m | 36.7m | 34.8m | 34.8m | |
| Additional Financial Items | ||||||||||||
| Capitalized Computer Software, Amortization | $269k | $414k | $632k | $900k | $800k | $1.1m | $500k | $500k | $500k | — | — | |
| Cost, Depreciation and Amortization | — | — | — | — | — | — | $10.8m | — | — | — | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $7.9m | $0 | $20.0m | — | — | — | $13.0m | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $18.9m | $15.0m | $16.4m | $3.6m | $51.3m | $40.5m | $52.1m | $63.9m | $9.5m | ($38.7m) | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $18.9m | $15.0m | $25.8m | $2.1m | ($38.2m) | ($32.7m) | ($63.5m) | ($64.2m) | $9.3m | $38.7m | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $18.9m | $15.0m | ($838k) | ($1.7m) | $0 | $0 | ($51.2m) | ($35.3m) | $2.7m | $38.7m | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | $18.9m | $15.0m | $16.4m | $3.6m | $51.3m | $40.5m | $52.1m | $63.9m | $9.5m | $0 | — |